Literature DB >> 7281102

The inhibitor of prothrombin conversion in plasma of patients on oral anticoagulant treatment.

R M Bertina, M E Westhoek-Kuipers, G H Alderkamp.   

Abstract

Pooled plasma of patients under stable oral anticoagulation has been analysed with respect to the presence of the vitamin-K dependent factors (factors II, VII, IX and X). Of all factors 1.5-2 times more antigen than procoagulant activity was present. The concentration of factors II, X (measured spectrophotometrically) and VI is about 0.25 U/ml while factor IX is slightly higher. Coagulation assays of factor X always gave lower values than the spectrophotometric assay. This discrepancy was not influenced by the removal of either factor II-, factor VII- or factor IX antigen. However, when the factor X antigen was replaced by normal factor X, all factor X assay gave identical results, indicating that PIVKA X is responsible for these discrepancies. Using the technic of the Thrombotest-dilution curve it was shown that PIVKA X is the factor that causes the abnormal prolongation of ox-brain prothrombin time in these plasmas.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7281102

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  7 in total

Review 1.  Complications of long-term home total parenteral nutrition: their identification, prevention and treatment.

Authors:  A L Buchman
Journal:  Dig Dis Sci       Date:  2001-01       Impact factor: 3.199

2.  Aging-associated changes in indices of thrombin generation and protein C activation in humans. Normative Aging Study.

Authors:  K A Bauer; L M Weiss; D Sparrow; P S Vokonas; R D Rosenberg
Journal:  J Clin Invest       Date:  1987-12       Impact factor: 14.808

3.  [Protein C deficiency--a risk factor for venous thrombosis].

Authors:  H G Klingemann; A W Broekmans; R M Bertina; R Egbring; E A Loeliger
Journal:  Klin Wochenschr       Date:  1984-10-15

4.  Suppression of hemostatic system activation by oral anticoagulants in the blood of patients with thrombotic diatheses.

Authors:  E M Conway; K A Bauer; S Barzegar; R D Rosenberg
Journal:  J Clin Invest       Date:  1987-12       Impact factor: 14.808

5.  Effectiveness of long term oral anticoagulation treatment in preventing venous thrombosis in hereditary protein S deficiency.

Authors:  J J Michiels; J Stibbe; R Bertina; A Broekmans
Journal:  Br Med J (Clin Res Ed)       Date:  1987-09-12

6.  Binding of human blood-coagulation Factors IXa and X to phospholipid membranes.

Authors:  K Mertens; R Cupers; A Van Wijngaarden; R M Bertina
Journal:  Biochem J       Date:  1984-11-01       Impact factor: 3.857

7.  Monoclonal anti-human factor VII antibodies. Detection in plasma of a second protein antigenically and genetically related to factor VII.

Authors:  G J Broze; S Hickman; J P Miletich
Journal:  J Clin Invest       Date:  1985-09       Impact factor: 14.808

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.